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We compared whole blood dried on filter paper to the standard assay with frozen cell-free plasma for use in
the quantitation of the human immunodeficiency virus RNA load in blood. RNA values from filter paper,
corrected for the hematocrit, gave results comparable to those of the standard assay in terms of sensitivity and
reproducibility.
The measurement of human immunodeficiency virus (HIV)
RNA levels in plasma is rapidly becoming the most important
laboratory tool for staging HIV infection and for the manage-
ment of therapy (6, 7). However, quantitation of HIV levels in
plasma requires access to certain laboratory equipment which
may not be readily available in some settings. By the year 2000
the World Health Organization predicts that 30 million to 40
million new HIV infections will have occurred, with 90% of
these occurring in developing countries (5). Even the simple
act of centrifuging a tube of blood, aliquoting and freezing the
plasma, and subsequently shipping the plasma to a centralized
laboratory might prove difficult in some field situations, where
many clinical trials of new antiretroviral drugs and potential
HIV vaccines as well as transmission intervention studies will
be conducted in the future.
The purpose of this research was to develop a simple
method for collecting specimens for analysis of the HIV RNA
level in plasma that would yield accurate and reproducible
results without the need for electricity at the collection site.
Our ultimate goal is to obtain blood from a fingerstick or
heelstick, dry it on filter paper, and airmail it to a central
laboratory, thus avoiding the need for a skilled phlebotomist
and laboratory technician on site and also avoiding the need
for centrifuges, freezers, and dry ice for shipping. Dried blood
spots have been used for many years to screen for several
metabolic disorders such as phenylketonuria and sickle cell
disease. For HIV they have been used for the anonymous
screening of newborns to assess the seroprevalence of HIV
among childbearing women (4) and for the diagnosis of peri-
natal HIV infections by using HIV DNA (2, 3). More recently,
it has been reported that DNA obtained from dried blood
spots is suitable for gene sequence analysis (1). Consequently,
we decided to evaluate the possibility of using whole blood
dried onto filter paper for the quantitation of the HIV RNA
level in plasma.
One hundred four HIV-positive patients seen in the Uni-
versity of North Carolina’s adult and pediatric infectious dis-
ease clinics provided 4 ml of blood collected in EDTA for the
purposes of viral load testing. HIV RNA was quantitated from
100 ml of whole blood from each of 76 patients spotted in
quadruplicate onto Schleicher & Schuell no. 903 filter paper. A
total of 50 ml of whole blood from an additional 28 patients was
spotted in eight replicates onto Schleicher & Schuell Isocode
filter paper. The blood spots were dried overnight at room
temperature in a biohazard hood. We also used the whole
blood to determine the hematocrit (mean of two determina-
tions). Cell-free plasma obtained from the same tube of blood
was stored at 270°C. HIV type 1 (HIV-1) RNA levels were
determined by a commercially available nucleic acid sequence-
based amplification assay (NASBA; NASBA HIV-1 QT; Or-
ganon Teknika, Durham, N.C.). Two 50-ml aliquots of dried
blood spots were placed in 9 ml of NASBA lysis buffer, and the
mixture was rocked at room temperature for 2 h to isolate the
RNA, after which the filter papers were removed. The HIV-1
RNA from cell-free plasma was isolated by placing 100 ml of
plasma in 0.9 ml of NASBA lysis buffer. For the rest of the
procedure, the manufacturer’s instructions were followed, in-
cluding the use of diluted calibrators. The numbers of RNA
copies per milliliter of plasma from the spots were calculated
as follows: corrected number of spot RNA copies per milliliter
of plasma 5 (number of spot RNA copies per milliliter of
blood)/[(100 2 hematocrit)/100]. Blood from the first 76 pa-
tients was tested singly by using the no. 903 filter paper. Blood
from the remaining 28 patients was tested in duplicate by using
the Isocode filter paper. Some dried spots were stored at room
temperature for various lengths of time before testing.
We initially used the no. 903 paper to measure HIV-1 RNA
levels from dried blood spots, with encouraging results (Fig.
1A). However, a second lot of paper gave uninterpretable
results and we switched to Isocode paper, which is pretreated
with guanidinium isothiocyanate. The log10 hematocrit-cor-
rected RNA concentration from the two types of paper is
compared with the log10 RNA concentration from plasma in
Fig. 1A (no. 903 filter paper) and Fig. 1B (Isocode filter pa-
per). The diagonal line on each graph indicates where the
points would fall if the estimates from the dots and the plasma
were the same. Correlation coefficients were 0.88 (no. 903 filter
paper versus plasma) and 0.90 (Isocode filter paper versus
plasma). There is little evidence of a systematic difference
between the values from no. 903 filter paper and those from
plasma. The mean difference, 0.0478, was not statistically sig-
nificantly different from zero (P 5 0.33). Most (91%) of the
differences in RNA values between the no. 903 filter paper dots
and plasma were between 20.5 and 0.5 log10. However, the
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mean difference between values from plasma and Isocode filter
paper was significantly different from zero (mean 5 0.22; P ,
0.01). On average, then, the values from plasma were 1.66
times the values from the Isocode filter paper. The difference
did not vary systematically over the range of the data (Fig. 1B),
so the use of a correction factor for the Isocode paper might be
feasible.
We tried to correct RNA values from filter paper for the
hematocrit in three ways. Initially, we simply adjusted the RNA
value obtained from the filter paper for each patient’s hemat-
ocrit, producing the data shown in Fig. 1. Then we tried the use
of two constant correction factors. The first, 1.82, was derived
from the mean hematocrit of 45 for this cohort. The second,
2.0, was based on the assumption that the mean hematocrit was
close to 50. Use of a constant factor could be appropriate when
hematocrits are not available. The two constants produced very
similar results (data not shown).
The sensitivities of filter dot RNA and plasma RNA were
compared by classifying each RNA determination as above or
below the limit of detection (1,000 HIV RNA copies/ml). For
FIG. 1. (A) Log10 hematocrit-corrected HIV RNA concentrations for 55 patients tested with no. 903 filter paper plotted against the log10 RNA concentration for
the matching plasma sample. Samples for which either estimate was below the detection limits were excluded (n 5 21). The diagonal line indicates where points would
fall if the estimates from the dots and the plasma were the same (correlation coefficient 5 0.88). The points in the plot are roughly scattered around this line, indicating
that there is little evidence of a systematic difference between the two approaches. For 91% of the hematocrit-corrected dot values, the values were within threefold
(0.5 log10) of the value for plasma. (B) Mean log10 hematocrit-corrected HIV RNA concentrations for the Isocode filter paper plotted against the mean log10 RNA
concentration for the matching plasma sample (coefficient correlation 5 0.90). The points are shifted to the right, indicating that higher values were obtained in the
assay with plasma. The mean difference was 0.22 (P 5 0.0016), meaning that, on average, the estimates from the plasma were 1.66 times the estimates from the Isocode
filter paper. For 95% of the hematocrit-corrected dot values, the values were within threefold (0.5 log10) of the value for plasma.
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21 of 76 (28%) samples, values from no. 903 filter paper were
below the detection limit, whereas for 17 of 76 (22%) samples,
values from plasma were below the detection limit. For 13
samples, values from both no. 903 filter paper and plasma were
below the detection limits. For 9 of 28 (32%) samples at least
one of two values was below the detection limit on the Isocode
filter paper, whereas for 7 (25%) samples at least one of two
values from plasma were below the detection limit. For six
samples two values from both Isocode filter paper and plasma
were below the detection limits. The sensitivities of assays with
filter dot RNA and plasma RNA were not significantly differ-
ent (P . 0.05), but these results should be interpreted with
caution. The volume of plasma on the filter paper dots is
roughly half the volume in the plasma assay, so a difference in
sensitivity should be expected. The absence of such a difference
could simply mean that the study included few patients with
RNA concentrations in the range needed to show a difference.
Alternatively, it may reflect the fact that the HIV-1 RNA from
the dried blood spots included both cell-free and cell-associ-
ated HIV-1 RNA, while the HIV-1 RNA quantitated from
plasma is essentially only cell-free RNA.
The reproducibility of RNA values was examined by using
intra-assay standard deviations (SDs) that were estimated from
the duplicate day 0 results for 17 patients from both Isocode
paper and plasma. The SDs for Isocode filter paper and plasma
were 0.19 and 0.15, respectively. However, one pair of Isocode
filter paper values differed by almost 0.7 log10. This large dif-
ference may reflect a specimen handling error rather than a
problem with reproducibility. When this point is excluded, the
SD drops to 0.17, which is close to the SD for plasma. For
comparison, in a multicenter evaluation of quantitative assays
of HIV-1 RNA levels in plasma, the AIDS Clinical Trials
Group virology laboratories determined that the intra-assay
SD for NASBA was 0.15 (8).
The stability of estimates from Isocode filter paper was ex-
amined by using a random effects regression of the log10 RNA
level on length of storage (in days). The results for blood from
14 patients, each with storage times of 0, 7, and 28 days, were
included. Nine values that were less than the detection limits
were set equal to 3.0 (1,000 HIV RNA copies/ml). A statisti-
cally significant decline of 0.0261 log10 RNA copies per day was
detected (P , 0.01). This slope is equivalent to a loss of
approximately 5% per day.
Initial results for the no. 903 filter paper looked very good.
However, later results with a different lot of no. 903 filter paper
were not reproducible. It may be that this paper should be
handled with gloved hands at all stages, including prior to the
application of blood, to avoid contamination with RNases
present on fingers; this may not be possible in all situations.
The Isocode paper is pretreated with guanidinium isothiocya-
nate, so it does not require special handling prior to applica-
tion of the specimen.
The preliminary results reported here are extremely encour-
aging. Using the Isocode filter paper and correcting for hemat-
ocrit and even without correcting for the use of the Isocode
filter paper, we were able to quantify the amount of HIV RNA
in plasma fairly accurately (Fig. 1B). No difference in sensitiv-
ity was observed between the assays with Isocode filter paper
and the plasma. The reproducibility of the results of assays
with Isocode filter paper were comparable to the reproducibil-
ity of the results of the standard assay with plasma. However,
problems with stability exist. We are not sure whether the
RNA is being degraded with time or whether we are simply
having increased difficulty in removing the RNA from the filter
paper with prolonged storage.
We believe that modifications and refinements of this
method can provide an accurate measurement of the plasma
HIV RNA level suitable for primitive field conditions. In ad-
dition, the nucleic acid recovered from the spots should be
amenable to amplification and sequencing and should thus be
of value for drug sensitivity and HIV clade testing (1).
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